Washington, DC 20006-5349
HELPLINE
For patients with MPM (Malignant Pleural Mesothelioma), the U.S. Food and Drug Administration (FDA) has approved KEYTRUDA® (pembrolizumab) as a first-line treatment when combined with pemetrexed and platinum-based chemotherapy. Keytruda(pembrolizumab) is an anti-programmed death receptor-1 (PD-1) therapy that works by increasing the ability of the body’s immune system to help…
Mesothelioma has often been classified as a cancer that only affects older people, as the average age of diagnosis for pleural is 72 and peritoneal is 67. This assumption of advanced age being a factor has led to misdiagnosis among younger patients. The demographic of meso patients is consistently changing…
The phase 3 clinical trial known as BEAT-meso, which combines chemotherapy plus bevacizumab with immunotherapy, has shown an improvement in overall survival (OS) and progression-free…
One of the many services that the Meso Foundation offers to patients, caregivers, and the bereaved community is support groups offered over Zoom video conferencing.…
The Meso Foundation’s International Symposium on Malignant Mesothelioma is a unique conference that brings together the entire mesothelioma community. We invite patients, their families, caregivers,…
The field of integrative medicine combines conventional therapies with complementary ones in a thoughtful way to optimize outcomes and/or quality of life. Services provided under…
Data from a positive phase 2/3 clinical trial evaluating the effectiveness of a drug for mesothelioma was just published in the Journal of the American…
Melina Marmarelis, MD, Thoracic Medical Oncologist, UPenn joins us for an interview about precision medicine for mesothelioma. She discusses biomarker information, such as histology (currently…
Hair loss, or alopecia, is often associated with cancer therapies and, in particular, with cytotoxic chemotherapy. While this side effect is most often temporary –…
Due to recent advances in cancer treatment, especially in the field of immunotherapy, chemotherapy treatment options for mesothelioma have taken a back seat. However, this…
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
